Schizophrenia and Insulin-requiring type 2 diabetes mellitus

Summary:

Insulin-requiring type 2 diabetes mellitus is found among people with Schizophrenia, especially for people who are male, 40-49 old.

The study analyzes which people have Insulin-requiring type 2 diabetes mellitus with Schizophrenia. It is created by eHealthMe based on reports of 34 people who have Schizophrenia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Schizophrenia?

Schizophrenia (a mental disorder characterized by a breakdown of thought processes) is found to be associated with 510 drugs and 724 conditions by eHealthMe. Check the latest studies of Schizophrenia.

What is Insulin-requiring type 2 diabetes mellitus?

Insulin-requiring type 2 diabetes mellitus is found to be associated with 72 drugs and 203 conditions by eHealthMe. Check the latest studies of Insulin-requiring type 2 diabetes mellitus.

On Jul, 17, 2026

34 people who have Schizophrenia and Insulin-Requiring Type 2 Diabetes Mellitus are studied.

Would you have Insulin-requiring type 2 diabetes mellitus when you have Schizophrenia?

Gender of people who have Schizophrenia and experienced Insulin-Requiring Type 2 Diabetes Mellitus *:

female: 32.35 %
male: 67.65 %

Age of people who have Schizophrenia and experienced Insulin-Requiring Type 2 Diabetes Mellitus *:

Common co-existing conditions for these people *:

Depression: 22 people, 64.71%
Bipolar Disorder (mood disorder): 12 people, 35.29%
Stress And Anxiety: 9 people, 26.47%
Affective Disorder (mental disorder): 4 people, 11.76%
High Blood Pressure: 4 people, 11.76%
Back Pain: 3 people, 8.82%
Pain: 3 people, 8.82%
Agitation (state of anxiety or nervous excitement): 3 people, 8.82%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 3 people, 8.82%
Psychotic Disorder: 3 people, 8.82%

Common drugs taken by these people *:

Common symptoms for these people *:

Diabetes: 22 people, 64.71%
Type 2 Diabetes: 17 people, 50.00%
Type 1 Diabetes: 11 people, 32.35%
Hyperglycemia (high blood sugar): 11 people, 32.35%
Diabetes Mellitus Inadequate Control: 11 people, 32.35%
Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 10 people, 29.41%
Pancreatitis (inflammation of pancreas): 9 people, 26.47%
Neuropathy Peripheral (surface nerve damage): 8 people, 23.53%
High Blood Cholesterol: 8 people, 23.53%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 5 people, 14.71%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Insulin-requiring type 2 diabetes mellitus?

- Check whether Insulin-requiring type 2 diabetes mellitus is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Schizophrenia (130,798 reports)
Insulin-requiring type 2 diabetes mellitus (3,654 reports)

All the drugs that are associated with Insulin-requiring type 2 diabetes mellitus:

Insulin-requiring type 2 diabetes mellitus (72 drugs)

All the conditions that are associated with Insulin-requiring type 2 diabetes mellitus:

Insulin-requiring type 2 diabetes mellitus (203 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Insulin-requiring type 2 diabetes mellitus and Schizophrenia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.